EP 1178798 A1 20020213 - PARENTERAL FORMULATION OF 5-(2-CHLOROETHYL)-4-METHYLTHIAZOLE EDISYLATE(CLOMETHIAZOLE EDISYLATE)
Title (en)
PARENTERAL FORMULATION OF 5-(2-CHLOROETHYL)-4-METHYLTHIAZOLE EDISYLATE(CLOMETHIAZOLE EDISYLATE)
Title (de)
PARENTERALE FORMULIERUNG VON 5-(2-CHLOROETHYL)-4-METHYLTHIAZOL EDISYLAT (CLOMETHIAZOL EDISYLAT)
Title (fr)
FORMULATION PARENTERALE DE 5-(2-CHLOROETHYLE)-4-METHYLTHIAZOLE EDISYLATE(CLOMETHIAZOLE EDISYLATE)
Publication
Application
Priority
- SE 0000876 W 20000504
- SE 9901658 A 19990506
Abstract (en)
[origin: WO0067753A1] The present invention relates to a parenteral formulation of 5-(2-chloroethyl)-4-methylthiazole edisylate (generically known as clomethiazole edisylate) having improved antimicrobial properties in addition to physical, chemical and microbiological stability as well as biological compatibility.
IPC 1-7
IPC 8 full level
A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 31/426 (2006.01); A61K 47/02 (2006.01); A61K 47/04 (2006.01); A61P 9/10 (2006.01); A61P 25/00 (2006.01); A61P 25/28 (2006.01); C07D 277/22 (2006.01)
CPC (source: EP)
A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 31/426 (2013.01); A61K 47/02 (2013.01); A61P 9/10 (2017.12); A61P 25/00 (2017.12); A61P 25/28 (2017.12); C07D 277/22 (2013.01)
Citation (search report)
See references of WO 0067753A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0067753 A1 20001116; AR 023873 A1 20020904; AU 4792200 A 20001121; EP 1178798 A1 20020213; JP 2002544164 A 20021224; SE 9901658 D0 19990506; TN SN00094 A1 20020530
DOCDB simple family (application)
SE 0000876 W 20000504; AR P000102193 A 20000505; AU 4792200 A 20000504; EP 00930026 A 20000504; JP 2000616779 A 20000504; SE 9901658 A 19990506; TN SN00094 A 20000503